Development of an assay to screen for inhibitors of tau phosphorylation by cdk5

A high-throughput assay for tau phosphorylation by cdk5/p25 is described. Full-length recombinant tau was used as a substrate in the presence of saturating adenosine triphosphate (ATP). Using PHF-1, an antibody directed specifically against 2 tau phosphorylation epitopes (serine 396 and serine 404),...

Full description

Saved in:
Bibliographic Details
Published inJournal of biomolecular screening Vol. 9; no. 2; pp. 122 - 131
Main Authors Ahn, Jae Suk, Musacchio, Andrea, Mapelli, Marina, Ni, Jake, Scinto, Leonard, Stein, Ross, Kosik, Kenneth S, Yeh, Li-An
Format Journal Article
LanguageEnglish
Published United States 01.03.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A high-throughput assay for tau phosphorylation by cdk5/p25 is described. Full-length recombinant tau was used as a substrate in the presence of saturating adenosine triphosphate (ATP). Using PHF-1, an antibody directed specifically against 2 tau phosphorylation epitopes (serine 396 and serine 404), an enzyme-linked immunosorbent assay (ELISA)-based colorimetric assay was formatted in 384-well plates. The assay was validated by measuring kinetic parameters for cdk5/p25 catalysis and known inhibitors. Rate constants for the site-specific phosphorylations at the PHF-1 epitopes were determined and suggested preferential phosphorylation at these sites. The performance of this assay in a high-throughput format was demonstrated and used to identify inhibitors of tau phosphorylation at specific epitopes phosphorylated by cdk5/p25.
ISSN:1087-0571
2472-5552
DOI:10.1177/1087057103260594